Navigation Links
Researchers make case for standardized analysis of cardiac imaging
Date:3/13/2008

For accuracy's sake, medical professionals should use the same software for comparing and analyzing diagnostic heart images taken from different time periods and laboratories, a team of researchers has concluded.

The collaborative study, published in the January-February issue of the Journal of Nuclear Cardiology, involved physicians and researchers at Sacred Heart Medical Center in Eugene, the University of Oregon and Cedars-Sinai Medical Center in Los Angeles. The study, which involved images done on 328 heart patients at Sacred Heart, is part of an effort to standardize cardiac-image analyses to improve both diagnostics and patient care.

A lack of important consistency is evident from analyses now done with three widely used software packages, said Dr. Mathews Fish, medical director of nuclear cardiology at the Oregon Heart & Vascular Institute at Sacred Heart. Inconsistencies can occur, for example, he said, when comparing images done on over time or when results on a patient come from different labs.

Fish is part of a collaborative research project with Cedars-Sinai that includes a recently awarded grant from the National Institutes of Health (NIH) for the development of an automated high-performance system for analyzing cardiac SPECT (three dimensional) imaging. SPECT stands for single photon emission computed tomography, which uses gamma rays to create pictures of organs and their structures.

The recently published study is believed to be the first head-to-head comparison of the commercially available software used in such cardiac-related diagnostics.

Cardiac SPECT is performed in conjunction with stress testing to compare blood flow to the heart muscle when patients are at rest or stressed. The images are analyzed using computer software. The new study found significant differences in diagnostic performance and quantification of abnormalities in the state-of-the-art software packages being used for cardiac SPECT imaging.

Because of its high diagnostic accuracy in determining the presence of significant coronary artery disease and its ability to determine the risk of a heart attack, cardiac SPECT imaging has become a useful tool in the care of patients with suspected heart disease. Important management and treatment decisions are based not only on whether the test is abnormal, but also the degree of the abnormality, which is best determined by computer software.

The database used in the study to compare the various results was created and maintained by Santiago Lorenzo of Argentina, a doctoral student in the University of Oregons department of human physiology. Lorenzo adapted the results into Microsoft Access. "It was very useful to use since I had to constantly analyze the data in many different ways," he said. "Having the data organized made my job much easier."

Lorenzo's participation in the study was done as part of collaboration between the hospital and the UO's human physiology department.

"This study shows the tangible benefits of the Oregon Heart & Vascular Institutes research partnership with the University of Oregon," Fish said. "Such research performed locally in our own institutions greatly enhances the quality of medical outcomes and supports the use of the most appropriate and effective technology for the care of patients."


'/>"/>

Contact: Jim Barlow
jebarlow@uoregon.edu
541-346-3481
University of Oregon
Source:Eurekalert

Related medicine news :

1. Researchers find cause of severe allergic reaction to cancer drug
2. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
3. USC researchers find benefit for lymphoma patients in combined PET-CT scanning
4. Researchers ID behavioral risk factors for head and neck cancers
5. Red-light cameras increase crashes, researchers find
6. Leading researchers honored for progress in cancer prevention, detection and treatment
7. University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein
8. UCF researchers discover a new protein family implicated in inflammatory diseases
9. Size does matter: Researchers adapt drug dosing to body size
10. Burroughs Wellcome Fund grants $9.75 million towards translational researchers
11. Researchers Design Promising Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... ... of thousands of defective respirators, according to court documents and SEC filings. ... William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its ... partner for the Tamika Catchings Legacy Tour that will commemorate the Indiana ... hardwood basketball surfaces in all forms and levels of the game, Connor Sports has ...
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, ... biologics, consumer health and global clinical supply services, today announced two key appointments ... company’s continued investment and strategic growth plans in the Asia Pacific region. , ...
(Date:5/26/2016)... ... ... effort to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is ... the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of ... Mohebi says, “The positive response to the Snapchat videos we started last month has been ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse à ... destinés à l,intervention portant sur les membres ... OrbusNeich, entreprise mondiale spécialisée dans ... changer la vie, a élargi son portefeuille ...
Breaking Medicine Technology: